SCN5A channelopathy: arrhythmia, cardiomyopathy, epilepsy and beyond

Research output: Contribution to journalReview articleAcademicpeer-review

10 Citations (Scopus)

Abstract

Influx of sodium ions through voltage-gated sodium channels in cardiomyocytes is essential for proper electrical conduction within the heart. Both acquired conditions associated with sodium channel dysfunction (myocardial ischaemia, heart failure) as well as inherited disorders secondary to mutations in the gene SCN5A encoding for the cardiac sodium channel Nav1.5 are associated with life-threatening arrhythmias. Research in the last decade has uncovered the complex nature of Nav1.5 distribution, function, in particular within distinct subcellular subdomains of cardiomyocytes. Nav1.5-based channels furthermore display previously unrecognized non-electrogenic actions and may impact on cardiac structural integrity, leading to cardiomyopathy. Moreover, SCN5A and Nav1.5 are expressed in cell types other than cardiomyocytes as well as various extracardiac tissues, where their functional role in, e.g. epilepsy, gastrointestinal motility, cancer and the innate immune response is increasingly investigated and recognized. This review provides an overview of these novel insights and how they deepen our mechanistic knowledge on SCN5A channelopathies and Nav1.5 (dys)function. This article is part of the theme issue 'The heartbeat: its molecular basis and physiological mechanisms'.
Original languageEnglish
Article number20220164
Pages (from-to)20220164
JournalPhilosophical transactions of the Royal Society of London. Series B, Biological sciences
Volume378
Issue number1879
DOIs
Publication statusPublished - 19 Jun 2023

Keywords

  • SCN5A
  • arrhythmia
  • electrophysiology
  • genetics
  • ion channels

Cite this